• en
  • de
  • fr
  • it
  • The Swiss 3RCC funds innovative projects that offer the potential for advancement in the 3R Principle. Our funding opportunities can be found below, follow the specific scheme you are interested in to find out more information and the process for applications. 

    Funding opportunities

    The funding schemes available for the current funding cycle (2025-2028) are still in their planning phase, and so are subject to change. The Swiss 3RCC’s funding regulations can be found here.

    3Rs PROJECT GRANTS

    Our main call for project funding. Open to academic researchers based in Switzerland aiming for significant 3Rs advancement.

    read more

    3Rs DOCTORATE PROGRAMME

    The 3Rs Doctorate Programme funds PhD projects that advance the replacement, reduction and refinement of animal use in science. The programme is designed to build the next generation of researchers who bring 3Rs thinking into their work from the outset.

    read more

    KNOWLEDGE TRANSFER GRANT

    This grant funds short-term stays for Swiss-based researchers, technicians, or lab assistants to train directly with a group that developed a validated 3Rs approach, so they can bring that expertise back and implement it in their home lab.

    read more

    3Rs SUPPORT GRANT

    Support Grants fund smaller-scale, short-term 3Rs projects across Switzerland, where modest funding can make a real difference: implementing an established approach, generating preliminary data, or reaching a wider community of users. They cover the full breadth of the 3Rs, from developing non-animal models to refinements that improve animal welfare, united by the aim of delivering a tangible, shareable benefit to Swiss 3Rs practice.

    read more

    Apply for funding

    ABOUT OUR FUNDING

    FUNDED PROJECTS

    Our lab develops organs-on-chip (OOC) models, focusing on the lungs, liver and gut. We are creating vascularized tissues-on-chip (patent filed) that better mimic the tissue microenvironment, enabling interaction studies between the vascular systems and their surroundings.
    https://swiss3rcc.org/wp-content/uploads/2025/07/negar-vadhani.jpg, Ms. Negar Vahdani,

    ARTORG Center for Biomedical Engineering Research
    University of Bern

    , https://www.artorg.unibe.ch/research/ooc/group_members/persons/vahdani_negar/index_eng.html
    Generation of vascularized liver spheroid on-chip model for in-vitro infectious disease studies
    At my home lab I developed an air-liquid-interface in-vitro model of the red fox (Vulpes vulpes) respiratory tract to study host-parasite interactions in canids. This model is crucial for understanding the pathogenesis and immune responses in canid lungworm infections and can be extended to study further infectious pathogens, given that foxes are reservoirs for many infective agents. Our model is used for studies on the tissue-specific response to lungworm infections using transcriptomic and proteomic approaches.
    https://swiss3rcc.org/wp-content/uploads/2025/07/andreas-oehm.jpg, Dr Andreas Oehm,

    Institute of Parasitology
    University of Zurich

    , https://www.paras.uzh.ch/de/research/veterinaerparasitologie/Team/Andreas-W.-%C3%96hm.html
    Development, validation, and establishment of intestinal organoids to study host-parasite interactions in veterinary medicine
    The Centre of Experimental Rheumatology specializes in the investigation of rheumatic and skeletal disorders, including systemic sclerosis (SSc). SSc is a paradigm fibrotic disease characterized by multi-organ fibrosis, including the skin. Currently, tools to investigate SSc pathogenesis include traditional two-dimensional (2D) cell culture and animal models, both of which are established at our institute.
    https://swiss3rcc.org/wp-content/uploads/2025/07/astrid-hofman.jpeg, Ms Astrid Hofman,

    Department of Rheumatology
    University Hospital Zurich

    , https://www.usz.ch/en/team/astrid-hofman/
    Moving towards Personalized Medicine: Precision Cut Skin Slices to Model Gene-Responsive Signatures for Novel and Existing Therapies for Systemic Sclerosis Patients
  • en
  • de
  • fr
  • it
  • en
  • de
  • fr
  • it
  • en
  • de
  • fr
  • it